Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2013 Sep 1;6(5):953-63.
doi: 10.1161/CIRCHEARTFAILURE.112.000008.

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

Multicenter Study

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

Ryan J Tedford et al. Circ Heart Fail. .

Abstract

Background: Systemic sclerosis–associated pulmonary artery hypertension (SScPAH) has a worse prognosis compared with idiopathic pulmonary arterial hypertension (IPAH), with a median survival of 3 years after diagnosis often caused by right ventricular (RV) failure. We tested whether SScPAH or systemic sclerosis–related pulmonary hypertension with interstitial lung disease imposes a greater pulmonary vascular load than IPAH and leads to worse RV contractile function.

Methods and results: We analyzed pulmonary artery pressures and mean flow in 282 patients with pulmonary hypertension (166 SScPAH, 49 systemic sclerosis–related pulmonary hypertension with interstitial lung disease, and 67 IPAH). An inverse relation between pulmonary resistance and compliance was similar for all 3 groups, with a near constant resistance×compliance product. RV pressure–volume loops were measured in a subset, IPAH (n=5) and SScPAH (n=7), as well as SSc without PH (n=7) to derive contractile indexes (end-systolic elastance [Ees] and preload recruitable stroke work [Msw]), measures of RV load (arterial elastance [Ea]), and RV pulmonary artery coupling (Ees/Ea). RV afterload was similar in SScPAH and IPAH (pulmonary vascular resistance=7.0±4.5 versus 7.9±4.3 Wood units; Ea=0.9±0.4 versus 1.2±0.5 mm Hg/mL; pulmonary arterial compliance=2.4±1.5 versus 1.7±1.1 mL/mm Hg; P>0.3 for each). Although SScPAH did not have greater vascular stiffening compared with IPAH, RV contractility was more depressed (Ees=0.8±0.3 versus 2.3±1.1, P<0.01; Msw=21±11 versus 45±16, P=0.01), with differential RV-PA uncoupling (Ees/Ea=1.0±0.5 versus 2.1±1.0; P=0.03). This ratio was higher in SSc without PH (Ees/Ea=2.3±1.2; P=0.02 versus SScPAH).

Conclusions: RV dysfunction is worse in SScPAH compared with IPAH at similar afterload, and may be because of intrinsic systolic function rather than enhanced pulmonary vascular resistive and pulsatile loading.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Example of left ventricular pressure volume loops obtained via preload reduction with inferior vena cava balloon occlusion (IVCBO; top left) and Valsalva maneuver (top right). Relationship of end-systolic elastance (bottom left) and preload recrutiable stroke work (bottom right) by each preload reduction method (n=20 for each).
Figure 2
Figure 2
Pulmonary Vascular Resistance-Compliance Relationship. A)RPA vs. CPA in SScPAH (n=166) or IPAH (n=67). Data are fit by non-linear regression, and best fit curves given by CPA=0.70/ (0.082+RPA) and CPA=0.73/ (0.086+RPA), respectively. B) Log(RPA)-Log(CPA) plot shows overlapping data between groups (p=0.71 for group effect by analysis of covariance). C) Product of RPAxCPA for pulmonary or D) systemic vascular system, each plot versus respective mean pressure for patients in both SScPAH and IPAH. The RC product was highly constrained in the pulmonary system, with no significant difference between groups when controlling for age and pressure. The systemic RC product was far more variable (p<0.00001; F-test).
Figure 3
Figure 3
Pulmonary Vascular Resistance-Compliance Relationship. A) RPA vs. CPA in SScPAH (n=166) or SSc-ILD-PH (n=49). Data are fit by non-linear regression, and best fit curves given by CPA=0.70/ (0.082+RPA) and CPA=0.70/ (0.082+RPA), respectively. B) Log(RPA)-Log(CPA) plot shows overlapping data between groups (p=0.57 for group effect by analysis of covariance). C) Product of RPAxCPA for pulmonary or D) systemic vascular system, each plot versus respective mean pressure for patients in both SScPAH and SSc-ILD-PH.
Figure 4
Figure 4
Right Ventricular (RV) Pressure-Volume Loops in six patients, three with A) IPAH and three with B) SScPAH. Steady-state loops (left) in both cohorts show RV pressure rising throughout ejection and peaking at end-systole, consistent with increased RV afterload from PAH. The black dot identifies the end-systolic pressure-volume point, and the dashed line mean loop width (stroke volume). Ea was determined by the ratio of end systolic pressure to SV. In the loops generated during Valsalva maneuver (right), the data are all shifted upward due to the rise in intra-thoracic pressure, but while this is held, phase-2 of the Valsalva maneuver results in a beat-to-beat decline in filling volume, various PV relations including the end-systolic pressure volume relationship (black line). The slope is end-systolic elastance (Ees).
Figure 5
Figure 5
Steady-State signal-averaged right ventricular (RV) pressure-volume loops for IPAH (top) and SScPAH (bottom). Pressure rises throughout ejection consistent with increased afterload.
Figure 6
Figure 6
Steady-State signal-averaged right ventricular (RV) pressure-volume loops for patients without PH, SSc (top, n=7) and without SSc (bottom, n=1). The loops are more rectangular in shape than those in Figure 5, as pressure stays constant or decreases during ejection.

Similar articles

Cited by

References

    1. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972–2002. Annals of the Rheumatic Diseases. 2007;66:940–944. - PMC - PubMed
    1. Overbeek MJ, Vonk MC, Boonstra A, Voskuyl AE, Vonk-Noordegraaf A, Smit EF, Dijkmans BAC, Postmus PE, Mooi WJ, Heijdra Y, Grünberg K. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. European Respiratory Journal. 2009;34:371–379. - PubMed
    1. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right Ventricular Function in Cardiovascular Disease, Part II. Circulation. 2008;117:1717–1731. - PubMed
    1. Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, Housten T, Champion HC, Lechtzin N, Wigley FM, Girgis RE, Hassoun PM. Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2010;182:252–260. - PMC - PubMed
    1. Hesselstrand R, Wildt M, Ekmehag B, Wuttge DM, Scheja A. Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult. Scand J Rheumatol. 2011;40:127–132. - PubMed

Publication types

MeSH terms